Elia Sechi 1, Steven Messina 2, B Mark Keegan 1, Marina Buciuc 1, Sean J Pittock 3, Orhun H Kantarci 1, Brian G Weinshenker 1, Eoin P Flanagan 3
Affiliations expand
PMID: 32552535 DOI: 10.1177/1352458520929192
Abstract
Background: Progressive motor impairment anatomically attributable to prominent, focally atrophic lateral column spinal cord lesions (“critical lesions”) can be seen in multiple sclerosis (MS), for example, progressive hemiparetic MS.
Objective: The aim of this study was to investigate whether similar spinal cord lesions are more frequent in long-standing MS patients with secondary progressive motor impairment (secondary progressive MS (SPMS)) versus those maintaining a relapsing-remitting course (relapsing-remitting MS (RRMS)).
Methods: We retrospectively identified Olmsted County (MN, USA) residents on 31 December 2011 with (1) RRMS or SPMS for ⩾25 years, and (2) available brain and spine magnetic resonance imaging (MRI). A blinded neuroradiologist determined demyelinating lesion burden and presence of potential critical lesions (prominent focally atrophic spinal cord lateral column lesions).
Results: In total, 32 patients were included: RRMS, 18; SPMS, 14. Median (range) disease duration (34 (27-53) vs. 39 (29-47) years) and relapse number (4 (1-10) vs. 3 (1-15)) were similar. In comparison to RRMS, SPMS patients more commonly showed potential critical spinal cord lesions (8/18 (44%) vs. 14/14 (100%)), higher spinal cord (median (range) 4 (1-7) vs. 7.5 (3-12)), and brain infratentorial (median (range) 1 (0-12) vs. 2.5 (1-13)) lesion number; p < 0.05. By multivariate analysis, only the presence of potential critical lesions independently associated with motor progression (p = 0.02).
Conclusion: Critical spinal cord lesions may be important contributors to motor progression in MS.
Keywords: MRI; Multiple sclerosis; T2 lesions; demyelination; outcome; spinal cord.
https://pubmed.ncbi.nlm.nih.gov/32552535/
Click to Subscribe for the MS Beacon eNewsletter and MS educational events
